ArticleAnti-cancer drugs2026

Eugenol as a game-changer: overcoming osimertinib resistance in non-small cell lung cancer by inhibiting glycolysis via the tripartite motif containing 59/extracellular signal-regulated kinase pathway.

Kun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.